Literature DB >> 31172457

Characterization and Isolation of Very Small Embryonic-like (VSEL) Stem Cells Obtained from Various Human Hematopoietic Cell Sources.

Serap Erdem Kuruca1, Dolay Damla Çelik1, Dilşad Özerkan2, Gökçe Erdemir3.   

Abstract

Stem cell transplantation is one of the available treatments for leukemia, lymphoma, hereditary blood diseases and bone marrow failure. Bone marrow (BM), peripheral blood progenitor cells (PBPC), and cord blood (CB) are the predominant sources of stem cells. Recently a new type of stem cell with a pluripotent potential has been identified. These cells were named "very small embryonic like stem cells (VSELs)". It is claimed that VSEL stem cells can be found in adult BM, peripheral blood (PB), CB and other body tissues. This study is designed to characterize and isolate VSEL stem cells from different human hematopoietic sources; CB, PB and apheresis material (PBPC). VSEL stem cells were isolated from MNC and erythrocyte layers for all materials by using centrifugation and ficoll gradient method. We determined embryonic markers by flow cytometry, immunofluorescence and western blotting methods. Results from western blotting and immunofluorescence show high level of NANOG and OCT4 protein expression in PB, apheresis material and CB. Immunofluorescence images showed cytoplasmic and nuclear presence of these proteins. Flow cytometry results exhibited a higher expression of VSELs markers on debris area than CD45- population and higher expression on CB than PB. As a result, these findings have shown that it is necessary to investigate the function of pluripotent stem cell markers in differentiated adult cells. We further conclude that erythrocyte lysis method had the highest cell recovery amount among erythrocyte lysis and ficoll gradient methods. Consequently, this study gives us new information and viewpoints about expression of pluripotent stem cell (PSC) markers in adult tissues.

Entities:  

Keywords:  Apheresis; Cord blood; Peripheral blood; Pluripotent stem cell markers; Very small embryonic-like (VSEL) stem cells

Mesh:

Substances:

Year:  2019        PMID: 31172457     DOI: 10.1007/s12015-019-09896-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  29 in total

1.  Stem cell therapy, regenerative medicine and hematopoietic stem cell transplantation: recent achievements.

Authors:  Paolo Perseghin
Journal:  Transfus Apher Sci       Date:  2012-07-04       Impact factor: 1.764

Review 2.  Clinical use of umbilical cord blood hematopoietic stem cells.

Authors:  Vanderson Rocha; Eliane Gluckman
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

3.  Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report.

Authors:  M Kucia; M Halasa; M Wysoczynski; M Baskiewicz-Masiuk; S Moldenhawer; E Zuba-Surma; R Czajka; W Wojakowski; B Machalinski; M Z Ratajczak
Journal:  Leukemia       Date:  2006-11-30       Impact factor: 11.528

4.  Allogeneic and autologous mode of stem cell transplantation in regenerative medicine: which way to go?

Authors:  Murali Krishna Mamidi; Susmita Dutta; Ramesh Bhonde; Anjan Kumar Das; Rajarshi Pal
Journal:  Med Hypotheses       Date:  2014-10-19       Impact factor: 1.538

Review 5.  Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine.

Authors:  Hong Lu; Cheng Xie; Yi-Min Zhao; Fa-Ming Chen
Journal:  Cell Transplant       Date:  2012-10-01       Impact factor: 4.064

6.  Processing of human cord blood by three different procedures for red blood cell depletion and mononuclear cell recovery.

Authors:  P Perutelli; S Catellani; L Scarso; P Cornaglia-Ferraris; G Dini
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

Review 7.  "Small stem cells" in adult tissues: very small embryonic-like stem cells stand up!

Authors:  Ewa K Zuba-Surma; Magdalena Kucia; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Cytometry A       Date:  2009-01       Impact factor: 4.355

8.  Hematopoietic stem cell transplantation: clinical use and perspectives.

Authors:  Francisco Barriga; Pablo Ramírez; Angélica Wietstruck; Nicolás Rojas
Journal:  Biol Res       Date:  2012       Impact factor: 5.612

9.  A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow.

Authors:  M Kucia; R Reca; F R Campbell; E Zuba-Surma; M Majka; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2006-05       Impact factor: 11.528

Review 10.  Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

Authors:  Dan S Kaufman
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

View more
  5 in total

Review 1.  Sources, Characteristics, and Therapeutic Applications of Mesenchymal Cells in Tissue Engineering.

Authors:  Rosa Angelica Gonzalez-Vilchis; Angelica Piedra-Ramirez; Carlos Cesar Patiño-Morales; Concepcion Sanchez-Gomez; Nohra E Beltran-Vargas
Journal:  Tissue Eng Regen Med       Date:  2022-01-29       Impact factor: 4.169

2.  Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes.

Authors:  Hongxiao Li; Jianjun Gu; Xiaolin Sun; Qisheng Zuo; Bichun Li; Xiang Gu
Journal:  Stem Cell Rev Rep       Date:  2022-08-04       Impact factor: 6.692

3.  Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020.

Authors:  Yendry Ventura-Carmenate; Fatima Mohammed Alkaabi; Yandy Marx Castillo-Aleman; Carlos Agustin Villegas-Valverde; Yasmine Maher Ahmed; Pierdanilo Sanna; Ayesha Abdulla Almarzooqi; Abeer Abdelrazik; Gina Marcela Torres-Zambrano; Maura Wade-Mateo; David Quesada-Saliba; Loubna Abdel Hadi; Antonio Alfonso Bencomo-Hernandez; Rene Antonio Rivero-Jimenez
Journal:  Transl Med Commun       Date:  2021-11-03

4.  SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Andrzej Ciechanowicz; Kasia Sielatycka; Monika Cymer; Wojciech Marlicz; Magda Kucia
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

Review 5.  The Blood Circulating Rare Cell Population. What is it and What is it Good For?

Authors:  Stefan Schreier; Wannapong Triampo
Journal:  Cells       Date:  2020-03-25       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.